Apolipoprotein E as a target for developing new therapeutics for Alzheimer’s disease based on studies from protein, RNA, and regulatory region of the gene

Author： Lahiri Debomoy  

Publisher： Humana Press, Inc

ISSN： 0895-8696

Source： Journal of Molecular Neuroscience, Vol.23, Iss.3, 2004-10, pp. : 225-233

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Apolipoprotein E4 as a target for developing new therapeutics for Alzheimer’s disease

By Refolo Lorenzo   Fillit Howard  

Journal of Molecular Neuroscience, Vol. 23, Iss. 3, 2004-10 ,pp. : 151-155

Humana Press, Inc

Access to resources Recommend Favorite

Apolipoprotein E-related neurotoxicity as a therapeutic target for Alzheimer’s disease

By Marques Marcos   Crutcher Keith  

Journal of Molecular Neuroscience, Vol. 20, Iss. 3, 2003-08 ,pp. : 327-337

Humana Press, Inc

Access to resources Recommend Favorite

Clinical Relevance of Apolipoprotein E Genotyping Based on a Family History of Alzheimer's Disease

By  

Current Alzheimer Research, Vol. 12, Iss. 3, 2015-01 ,pp. : 210-217

Bentham Science Publishers

Access to resources Recommend Favorite

Tuberin – A New Molecular Target in Alzheimer’s Disease?

By Ferrando-Miguel Rosa   Rosner Margit   Freilinger Angelika   Lubec Gert   Hengstschläger Markus  

Neurochemical Research, Vol. 30, Iss. 11, 2005-11 ,pp. : 1413-1419

Springer Publishing Company

Access to resources Recommend Favorite

Apolipoprotein E is a prime suspect, not just an accomplice, in Alzheimer’s disease

By Crutcher Keith  

Journal of Molecular Neuroscience, Vol. 23, Iss. 3, 2004-10 ,pp. : 181-188

Humana Press, Inc

Access to resources Recommend Favorite